Venture Certified
| 혁신성장유형 | 2023-05-24 ~ 2026-05-23 | 20230524030116 | 2023-05-24 |
Revenue CAGR +29.3%
| Item | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 102.6B | 78.0B | 61.4B |
| Operating Profit | 6.4B | 2.8B | 2.6B |
| Net Profit | 5.7B | 2.3B | 2.8B |
| Total Assets | 41.1B | 32.4B | 22.2B |
| Total Liabilities | 25.3B | 20.9B | 12.7B |
| Total Equity | 15.9B | 11.5B | 9.5B |
▲ 47.2%
▲ 139.6%
▲ 61.2%
▲ 1.2%
▲ 46.2%
| Name | Position | Role |
|---|---|---|
| 조기환 | 대표이사 | 대표 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
1 Additional Data Sources
{
"address": "서울특별시 서초구",
"ceo_name": "조기환",
"certificate": [
{
"cert_number": "20230524030116",
"changes": "기업명, 소재지",
"disclosure_date": "2023-05-24",
"first_cert_date": "2023-05-24",
"no": "1",
"type": "혁신성장유형",
"valid_period": "2023-05-24 ~ 2026-05-23"
}
],
"company_name": "(주)에머티바이오",
"corp_no": "110111-*******",
"financials": {
"2022": {
"capital_stock": 500000000,
"cost_of_sales": 4993493000,
"current_assets": 2058806000,
"current_liabilities": 354977000,
"gross_profit": 1145354000,
"net_income": 276411000,
"net_income_bs": 271693000,
"non_current_assets": 159919000,
"non_current_liabilities": 912500000,
"non_operating_expenses": 55845000,
"non_operating_income": 76919000,
"operating_profit": 255337000,
"revenue": 6138847000,
"sga_expenses": 890017000,
"total_assets": 2218725000,
"total_equity": 951248000,
"total_liabilities": 1267477000
},
"2023": {
"capital_stock": 500000000,
"cost_of_sales": 5924566000,
"current_assets": 2992902000,
"current_liabilities": 789983000,
"gross_profit": 1879399000,
"net_income": 231951000,
"net_income_bs": 228468000,
"non_current_assets": 246797000,
"non_current_liabilities": 1300000000,
"non_operating_expenses": 57432000,
"non_operating_income": 14221000,
"operating_profit": 275162000,
"revenue": 7803965000,
"sga_expenses": 1604237000,
"total_assets": 3239699000,
"total_equity": 1149716000,
"total_liabilities": 2089983000
},
"2024": {
"capital_stock": 500000000,
"cost_of_sales": 5809186000,
"current_assets": 3664044000,
"current_liabilities": 626632000,
"gross_profit": 4452684000,
"net_income": 570364000,
"net_income_bs": 535654000,
"non_current_assets": 447908000,
"non_current_liabilities": 1899950000,
"non_operating_expenses": 80887000,
"non_operating_income": 15605000,
"operating_profit": 635646000,
"revenue": 10261870000,
"sga_expenses": 3817038000,
"total_assets": 4111952000,
"total_equity": 1585370000,
"total_liabilities": 2526582000
}
},
"industry": "의약품 도매업",
"investment": [],
"main_products": "의약품판매, 의약품판매대행",
"phone": "02-3394-****",
"years": [
2024,
2023,
2022
]
}Data Quality: 8/10 | Primary Source: Venture System | Section Coverage: 7/8
| Section | Source: | Status |
|---|---|---|
| Basic Info | Public Data | Collected |
| Financial Statements | Venture System | Collected |
| Investment Metrics | Venture System | Collected |
| Officers | Public Data | Collected |
| Employment | Not Collected | Not Collected |
| Certifications | Public Data | Collected |
| Patents | KIPRIS | Collected |
| Procurement | G2B Procurement | Collected |
| API | Collected | Status |
|---|---|---|
| G2B Procurement | 2026-02-25 | Collected |
| KIPRIS Patents | 2026-02-25 | Collected |
| Employment Insurance | 2026-02-25 | Collected |
| HomeTax Business | 2026-02-25 | Collected |
| Cert. Info | 2026-02-25 | Collected |
| Venture System Detail | 2026-02-25 | Collected |